As administrators, we are forced to juggle more and more because of the Affordable Care Act and its plans to improve the cost of healthcare in the United States. Measuring quality improvement is a great idea, but shouldn’t we have been doing this all along? These last 20 years in the medical field have taught me the good and the bad side of medicine, and practice administrators fight the fight each day.
My grandmother always told me, “Buy the best you can afford.” Contained in this simple advice, something we all have likely heard in one form or another, are a couple of key concepts worth extracting as they pertain to the oncology industry: the words “buy” and “best.”
Quite often I am asked what constitutes “good” oncology care. Many people have their opinions; patients, doctors, allied medical professionals, and even health plan administrators like to weigh in on this issue...
The Commission on Cancer (CoC) of the American College of Surgeons is a consortium of professional organizations with the mission to improve survival and quality of life for patients with cancer through standard setting, prevention, research, education, and the monitoring of comprehensive quality cancer care.1 Earlier this year, the CoC released a revised set of standards (www.facs.org/cancer/coc/cocprogramstandards2012.pdf) with improvements focusing on the enhancement of patient-centered functions, as well as the provision of performance criteria in quality measurement and outcomes.1
Quality reporting is one of the cornerstones of the healthcare reform. Now is the time to integrate quality improvement mechanisms at your cancer center, suggested Cynthia Jones, BSHA, CPHQ, Quality Program Coordinator at Rex Cancer Center, NC, at the 2012 Association of Community Cancer Centers meeting.
Results 1 - 5 of 5